Chi-Huey Wong

Find an error

Name: Wong, Chi Huey; William A. Greenberg
Organization: Department of Chemistry and the Skaggs Institute for Chemical Biology , USA
Department: Department of Chemistry and the Skaggs Institute for Chemical Biology
Title: Professor(PhD)

TOPICS

Co-reporter:Ryan M. Schmaltz, Sarah R. Hanson, and Chi-Huey Wong
Chemical Reviews 2011 Volume 111(Issue 7) pp:4259
Publication Date(Web):July 13, 2011
DOI:10.1021/cr200113w
Co-reporter:Che-Hsiung Hsu; Shang-Cheng Hung; Chung-Yi Wu; Chi-Huey Wong
Angewandte Chemie International Edition 2011 Volume 50( Issue 50) pp:11872-11923
Publication Date(Web):
DOI:10.1002/anie.201100125

Abstract

Carbohydrates have been shown to play important roles in biological processes. The pace of development in carbohydrate research is, however, relatively slow due to the problems associated with the complexity of carbohydrate structures and the lack of general synthetic methods and tools available for the study of this class of biomolecules. Recent advances in synthesis have demonstrated that many of these problems can be circumvented. In this Review, we describe the methods developed to tackle the problems of carbohydrate-mediated biological processes, with particular focus on the issue related to the development of the automated synthesis of oligosaccharides. Further applications of carbohydrate microarrays and vaccines to human diseases are also highlighted.

Co-reporter:Hsin-Yu Liao ; Che-Hsiung Hsu ; Shih-Chi Wang ; Chi-Hui Liang ; Hsin-Yung Yen ; Ching-Yao Su ; Chien-Hung Chen ; Jia-Tsrong Jan ; Chien-Tai Ren ; Chung-Hsuan Chen ; Ting-Jen R. Cheng ; Chung-Yi Wu
Journal of the American Chemical Society 2010 Volume 132(Issue 42) pp:14849-14856
Publication Date(Web):September 30, 2010
DOI:10.1021/ja104657b
A library of 27 sialosides, including seventeen 2,3-linked and ten 2,6-linked glycans, has been prepared to construct a glycan array and used to profile the binding specificity of different influenza hemagglutinins (HA) subtypes, especially from the 2009 swine-originated H1N1 and seasonal influenza viruses. It was found that the HAs from the 2009 H1N1 and the seasonal Brisbane strain share similar binding profiles yet different binding affinities toward various α2,6 sialosides. Analysis of the binding profiles of different HA subtypes indicate that a minimum set of 5 oligosaccharides can be used to differentiate influenza H1, H3, H5, H7, and H9 subtypes. In addition, the glycan array was used to profile the binding pattern of different influenza viruses. It was found that most binding patterns of viruses and HA proteins are similar and that glycosylation at Asn27 is essential for receptor binding.
Co-reporter:Charng-Sheng Tsai, Po-Yu Liu, Hsin-Yung Yen, Tsui-Ling Hsu and Chi-Huey Wong  
Chemical Communications 2010 vol. 46(Issue 30) pp:5575-5577
Publication Date(Web):13 May 2010
DOI:10.1039/C0CC00345J
A new trifunctional probe, assembled using a cleavable linker, is useful for efficient enrichment and detection of alkynyl sugar-tagged biomolecules.
Co-reporter:Zhangyong Hong ; Lei Liu ; Masakazu Sugiyama ; Yu Fu
Journal of the American Chemical Society 2009 Volume 131(Issue 24) pp:8352-8353
Publication Date(Web):May 28, 2009
DOI:10.1021/ja901656e
A two-step method has been developed to synthesize several biologically important iminocyclitols in ca. 44−60% yields by using Petasis-type condensation. The method is very general and operationally simple, affording a series of iminocyclitols from easily available sugar derivatives. Unexpected diastereoselectivities are observed, suggesting that the condensation may proceed through a five- or six-membered cyclic iminium ion intermediate.
Co-reporter:Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2009 Volume 17(Issue 3) pp:950
Publication Date(Web):1 February 2009
DOI:10.1016/j.bmc.2009.01.036
Co-reporter:Sarah R. Hanson;Elizabeth K. Culyba;Tsui-Ling Hsu;Jeffery W. Kelly;Evan T. Powers
PNAS 2009 Volume 106 (Issue 9 ) pp:3131-3136
Publication Date(Web):2009-03-03
DOI:10.1073/pnas.0810318105
The folding energetics of the mono-N-glycosylated adhesion domain of the human immune cell receptor cluster of differentiation 2 (hCD2ad) were studied systematically to understand the influence of the N-glycan on the folding energy landscape. Fully elaborated N-glycan structures accelerate folding by 4-fold and stabilize the β-sandwich structure by 3.1 kcal/mol, relative to the nonglycosylated protein. The N-glycan's first saccharide unit accounts for the entire acceleration of folding and for 2/3 of the native state stabilization. The remaining third of the stabilization is derived from the next 2 saccharide units. Thus, the conserved N-linked triose core, ManGlcNAc2, improves both the kinetics and the thermodynamics of protein folding. The native state stabilization and decreased activation barrier for folding conferred by N-glycosylation provide a powerful and potentially general mechanism for enhancing folding in the secretory pathway.
Co-reporter:Pi-Hui Liang, Chung-Yi Wu, William A Greenberg, Chi-Huey Wong
Current Opinion in Chemical Biology 2008 Volume 12(Issue 1) pp:86-92
Publication Date(Web):February 2008
DOI:10.1016/j.cbpa.2008.01.031
Carbohydrates and their conjugates are involved in various biological events, including viral and bacterial infection, the immune response, differentiation and development, and the progression of tumor cell metastasis. Glycan arrays are a new technology that has enabled the high-sensitivity and rapid analysis carbohydrate–protein interaction and contribute to significant advances in glycomics. Glycan arrays use a minute amount of materials and can be used for high-throughput profiling and quantitative analysis and provide information for the development of carbohydrate-based vaccines and new drug discovery.
Co-reporter:Douglass Wu, Masakazu Fujio, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2008 Volume 16(Issue 3) pp:1073-1083
Publication Date(Web):1 February 2008
DOI:10.1016/j.bmc.2007.10.026
The processing and presentation of lipid antigens by antigen presenting cells (APC) is important for defense against infection, tumor immunosurveillance, and autoimmunity. CD1, a family of cell surface glycoproteins, is responsible for the binding and presentation of lipid antigens to receptors expressed on the surface of T lymphocytes. Among the several (glyco)lipids identified to cause T-cell stimulation in complex with CD1, α-galactosyl ceramide (α-GalCer) is one of the most well studied. A combination of structure–activity relationship (SAR), crystallographic studies, and discovery of new ‘natural’ antigens has led to greater understanding of the structural requirements for optimal natural killer T-cell activation.
Co-reporter:RichardJ. Payne Dr.;Simon Ficht Dr.;WilliamA. Greenberg
Angewandte Chemie International Edition 2008 Volume 47( Issue 23) pp:4411-4415
Publication Date(Web):
DOI:10.1002/anie.200705298
Co-reporter:Simon Ficht Dr.;RichardJ. Payne Dr.;RichardT. Guy Dr. Dr.
Chemistry - A European Journal 2008 Volume 14( Issue 12) pp:3620-3629
Publication Date(Web):
DOI:10.1002/chem.200701978

Abstract

An efficient new strategy for the synthesis of peptide and glycopeptide thioesters is described. The method relies on the side-chain immobilization of a variety of Fmoc-amino acids, protected at their C-termini, on solid supports. Once anchored, peptides were constructed using solid-phase peptide synthesis according to the Fmoc protocol. After unmasking the C-terminal carboxylate, either thiols or amino acid thioesters were coupled to afford, after cleavage, peptide and glycopeptide thioesters in high yields. Using this method a significant proportion of the proteinogenic amino acids could be incorporated as C-terminal amino acid residues, therefore providing access to a large number of potential targets that can serve as acyl donors in subsequent ligation reactions. The utility of this methodology was exemplified in the synthesis of a 28 amino acid glycopeptide thioester, which was further elaborated to an N-terminal fragment of the glycoprotein erythropoietin (EPO) by native chemical ligation.

Co-reporter:RichardJ. Payne Dr.;Simon Ficht Dr.;WilliamA. Greenberg
Angewandte Chemie 2008 Volume 120( Issue 23) pp:4483-4487
Publication Date(Web):
DOI:10.1002/ange.200705298
Co-reporter:Sheng-Kai Wang;Pi-Hui Liang;Rena D. Astronomo;Tsui-Ling Hsu;Shie-Liang Hsieh;Dennis R. Burton
PNAS 2008 Volume 105 (Issue 10 ) pp:3690-3695
Publication Date(Web):2008-03-11
DOI:10.1073/pnas.0712326105
It is widely accepted that the heavily glycosylated glycoprotein gp120 on the surface of HIV-1 shields peptide epitopes from recognition by the immune system and may promote infection in vivo by interaction with dendritic cells and transport to tissue rich in CD4+ T cells such as lymph nodes. A conserved cluster of oligomannose glycans on gp120 has been identified as the epitope recognized by the broadly HIV-1-neutralizing monoclonal antibody 2G12. Oligomannose glycans are also the ligands for DC-SIGN, a C-type lectin found on the surface of dendritic cells. Multivalency is fundamental for carbohydrate–protein interactions, and mimicking of the high glycan density on the virus surface has become essential for designing carbohydrate-based HIV vaccines and antiviral agents. We report an efficient synthesis of oligomannose dendrons, which display multivalent oligomannoses in high density, and characterize their interaction with 2G12 and DC-SIGN by a glycan microarray binding assay. The solution and the surface binding analysis of 2G12 to a prototype oligomannose dendron clearly demonstrated the efficacy of dendrimeric display. We further showed that these glycodendrons inhibit the binding of gp120 to 2G12 and recombinant dimeric DC-SIGN with IC50 in the nanomolar range. A second-generation Man9 dendron was identified as a potential immunogen for HIV vaccine development and as a potential antiviral agent.
Co-reporter:Jinq-Chyi Lee;Steven M. Yannone;Jason Raymond;Trent R. Northen;Linh Hoang;Der-Ren Hwang;Gary Siuzdak
PNAS 2008 Volume 105 (Issue 10 ) pp:3678-3683
Publication Date(Web):2008-03-11
DOI:10.1073/pnas.0712332105
We describe a Nanostructure-Initiator Mass Spectrometry (NIMS) enzymatic (Nimzyme) assay in which enzyme substrates are immobilized on the mass spectrometry surface by using fluorous-phase interactions. This “soft” immobilization allows efficient desorption/ionization while also enabling the use of surface-washing steps to reduce signal suppression from complex biological samples, which results from the preferential retention of the tagged products and reactants. The Nimzyme assay is sensitive to subpicogram levels of enzyme, detects both addition and cleavage reactions (sialyltransferase and galactosidase), is applicable over a wide range of pHs and temperatures, and can measure activity directly from crude cell lysates. The ability of the Nimzyme assay to analyze complex mixtures is illustrated by identifying and directly characterizing β-1,4-galactosidase activity from a thermophilic microbial community lysate. The optimal enzyme temperature and pH were found to be 65°C and 5.5, respectively, and the activity was inhibited by both phenylethyl-β-d-thiogalactopyranoside and deoxygalactonojirimycin. Metagenomic analysis of the community suggests that the activity is from an uncultured, unsequenced γ-proteobacterium. In general, this assay provides an efficient method for detection and characterization of enzymatic activities in complex biological mixtures prior to sequencing or cloning efforts. More generally, this approach may have important applications for screening both enzymatic and inhibitor libraries, constructing and screening glycan microarrays, and complementing fluorous-phase organic synthesis.
Co-reporter:Clay S. Bennett and Chi-Huey Wong  
Chemical Society Reviews 2007 vol. 36(Issue 8) pp:1227-1238
Publication Date(Web):14 May 2007
DOI:10.1039/B617709C
The construction of homogeneous glycoproteins presents a formidable challenge to the synthetic chemist. Over the past few years there has been an explosion in the number of methods developed to address this problem. These methods include the development of novel ligation technologies for the synthesis of the protein backbone, as well chemical and enzymatic approaches for introducing complex glycans into the peptide backbone. This tutorial review discusses the application of these techniques to the synthesis of peptides and proteins possessing well defined glycans.
Co-reporter:Stephen M. Dean;William A. Greenberg
Advanced Synthesis & Catalysis 2007 Volume 349(Issue 8-9) pp:
Publication Date(Web):4 JUN 2007
DOI:10.1002/adsc.200700115

This review is focused on advances over the last several years in the application of aldolases to organic synthesis. Several new technologies have been implemented to increase the scope and practicality of aldolases as tools for the synthetic chemist. These include directed evolution, discovery of new classes of aldolases in nature and the laboratory, and substrate and reaction engineering.

Co-reporter:Masakazu Sugiyama, Zhangyong Hong, William A. Greenberg, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2007 Volume 15(Issue 17) pp:5905-5911
Publication Date(Web):1 September 2007
DOI:10.1016/j.bmc.2007.05.062
Dihydroxyacetone phosphate (DHAP)-dependent aldolases have been widely used for organic synthesis. The major drawback of DHAP-dependent aldolases is their strict donor substrate specificity toward DHAP, which is expensive and unstable. Here we report the development of an in vivo selection system for the directed evolution of the DHAP-dependent aldolase, l-rhamnulose-1-phosphate aldolase (RhaD), to alter its donor substrate specificity from DHAP to dihydroxyacetone (DHA). We also report preliminary results on mutants that were discovered with this screen. A strain deficient in the l-rhamnose metabolic pathway in Escherichia coli (ΔrhaDAB, DE3) was constructed and used as a selection host strain. Co-expression of l-rhamnose isomerase (rhaA) and rhaD in the selection host did not restore its growth on minimal plate supplemented with l-rhamnose as a sole carbon source, because of the lack of l-rhamnulose kinase (RhaB) activity and the inability of WT RhaD aldolase to use unphosphorylated l-rhamnulose as a substrate. Use of this selection host and co-expression vector system gives us an in vivo selection for the desired mutant RhaD which can cleave unphosphorylated l-rhamnulose and allow the mutant to grow in the minimal media. An error-prone PCR (ep-PCR) library of rhaD gene on the co-expression vector was constructed and introduced into the rha-mutant, and survivors were selected in minimal media with l-rhamnose (MMRha media). An initial round of screening gave mutants allowing the selection strain to grow on MMRha plates. This in vivo selection system allows rapid screening of mutated aldolases that can utilize dihydroxyacetone as a donor substrate.
Co-reporter:Ashraf Brik Dr.  Dr.
Chemistry - A European Journal 2007 Volume 13(Issue 20) pp:
Publication Date(Web):16 MAY 2007
DOI:10.1002/chem.200700330

Chemical synthesis of glycoproteins from readily available materials is a powerful method for obtaining a pure product with full control of its atomic structure. Sugar-assisted ligation (SAL) is an emerging approach that allows the synthesis of a large glycopeptide from two unprotected fragments. Contrary to other ligation methods that are limited to the use of a cysteine residue or depend on external auxiliary, SAL takes advantage of the existing sugars in glycopeptides to promote proximity between the two peptides to facilitate an amide bond formation.

Co-reporter:Yi-Ming Shao;Wen-Bin Yang Dr.;Hung-Pin Peng;Min-Feng Hsu Dr.;Keng-Chang Tsai Dr.;Tun-Hsun Kuo;Andrew H.-J. Wang Dr.;Po-Huang Liang Dr.;Chun-Hung Lin Dr.;An-Suei Yang
ChemBioChem 2007 Volume 8(Issue 14) pp:
Publication Date(Web):23 AUG 2007
DOI:10.1002/cbic.200700254

In a successful example of lead optimization by computer modeling prediction, computational technology was used to optimize a lead inhibitor (TL-3) of the SARS-CoV 3CL protease. A novel C2-symmetric diol (1) was then designed and synthesized, and displayed higher affinity than the original lead compound by one order of magnitude in its inhibition constant (0.60.073 μM). We believe that this approach has provided a platform for further lead optimization.

Co-reporter:Ya-Jen Chang;Yi-Chien Tsai;Alice L. Yu;Jung-Tung Hung;Douglass Wu;Jing-Rong Huang;Masakazu Fujio
PNAS 2007 Volume 104 (Issue 25 ) pp:10299-10304
Publication Date(Web):2007-06-19
DOI:10.1073/pnas.0703824104
α-Galactosylceramide (α-GalCer), a glycolipid that stimulates natural killer T (NKT) cells to produce both T helper (Th)1 and Th2 cytokines, has shown antitumor effects in mice but failed in clinical trials. We evaluated 16 analogs of α-GalCer for their CD1-mediated T cell receptor (TCR) activation of naïve human NKT cells and their anticancer efficacy. In vitro, glycolipids containing an aromatic ring in their acyl tail or sphingosine tail were more effective than α-GalCer in inducing Th1 cytokines/chemokines, TCR activation, and human NKT cell expansion. None of these glycolipids could directly stimulate human dendritic cell maturation, except for a glycolipid with an aromatic ring on the sphingosine tail. Here, we show that glycolipids activated the TCR of NKT cells with phosphorylation of CD3ε, ERK1/2, or CREB, which correlated with their induction of Th1 cytokines. Notably, the extent of NKT cell activation when glycolipid was presented by antigen-presenting cells was greater than when glycolipid was presented by non-antigen-presenting cells. In vivo, in mice bearing breast or lung cancers, the glycolipids that induced more Th1-biased cytokines and CD8/CD4 T cells displayed significantly greater anticancer potency than α-GalCer. These findings indicate that α-GalCer analogs can be designed to favor Th1-biased immunity, with greater anticancer efficacy and other immune-enhancing activities than α-GalCer itself.
Co-reporter:Sarah R. Hanson;Sheng-Kai Wang;Tsui-Ling Hsu;Kuniyuki Kishikawa;Masaaki Sawa
PNAS 2007 Volume 104 (Issue 8 ) pp:2614-2619
Publication Date(Web):2007-02-20
DOI:10.1073/pnas.0611307104
Developing tools for investigating the cellular activity of glycans will help to delineate the molecular basis for aberrant glycosylation in pathological processes such as cancer. Metabolic oligosaccharide engineering, which inserts sugar-reporting groups into cellular glycoconjugates, represents a powerful method for imaging the localization, trafficking, and dynamics of glycans and isolating them for glyco-proteomic analysis. Herein, we show that the alkyne-reporting group can be incorporated into cellular glycans. The alkyne group is a small, inert, bio-orthogonal handle that can be chemoselectively labeled by using the Cu(I) catalyzed [3 + 2] azide-alkyne cycloaddition, or click chemistry. Alkynyl sugar monomers, based on fucose (Fuc) and N-acetylmannosamine (ManNAc), were incorporated into fucosylated and sialylated glycans in several cancer cell lines, allowing for cell surface and intracellular visualization of glycoconjugates, as well as, observation of alkyne-bearing glycoproteins. Similarly to our previous results with an azido Fuc/alkynyl probe system, we demonstrated that click-activated fluorogenic probes are practical tools for efficiently and selectively labeling alkynyl-modified glycans. Because Fuc and sialic acid are terminal glycan residues with a notably increased presence in many tumors, we hope that our method will provide useful information about their roles in cancer and ultimately can be used for diagnostic and therapeutic purposes.
Co-reporter:Simon Ficht;Richard J. Payne;Ashraf Brik Dr.
Angewandte Chemie International Edition 2007 Volume 46(Issue 31) pp:
Publication Date(Web):2 JUL 2007
DOI:10.1002/anie.200700546

Sweet ligations: A second-generation sugar-assisted ligation is described that incorporates a sugar moiety with an ester-linked thiol auxiliary. Efficient auxiliary removal leads to native glycopeptides without the use of protecting groups. Extended glycopeptides also facilitate efficient ligation reactions by this method, therefore making it possible to scan a target sequence until a synthetically viable ligation junction is found.

Co-reporter:Simon Ficht Dr.;Richard J. Payne Dr.;Ashraf Brik Dr.
Angewandte Chemie 2007 Volume 119(Issue 31) pp:
Publication Date(Web):2 JUL 2007
DOI:10.1002/ange.200700546

Süße Verknüpfungen: Eine zuckervermittelte Glycopeptidverknüpfung der zweiten Generation wird beschrieben, bei der ein Zuckerrest ein estergebundenes Auxiliar trägt (siehe Schema). Die Entfernung des Auxiliars führt ohne Schutzgruppenoperationen zu nativen Glycopeptiden. Verlängerte Glycopeptide können ebenfalls eingesetzt werden, sodass die Sequenz eines gewünschten Glycopeptids „abgetastet“ werden kann, bis eine günstige Verknüpfungsstelle gefunden ist.

Co-reporter:Lei Liu, Clay S. Bennett and Chi-Huey Wong  
Chemical Communications 2006 (Issue 1) pp:21-33
Publication Date(Web):23 Nov 2005
DOI:10.1039/B513165K
The development of chemical and enzymatic methods for the synthesis of homogeneous glycoproteins is a fascinating challenge at the interface between chemistry and biology. Discussed here are the currently available methods for preparation of homogeneous glycoproteins. These methods include (1) glycopeptide ligation; (2) glycoprotein remodeling; and (3) in vivo suppressor tRNA technology.
Co-reporter:Chung-Yi Wu, Ke-Yung King, Chih-Jung Kuo, Jim-Min Fang, Ying-Ta Wu, Ming-Yi Ho, Chung-Lin Liao, Jiun-Jie Shie, Po-Huang Liang, Chi-Huey Wong
Chemistry & Biology 2006 Volume 13(Issue 3) pp:261-268
Publication Date(Web):March 2006
DOI:10.1016/j.chembiol.2005.12.008
Severe acute respiratory syndrome (SARS) is caused by a newly emerged coronavirus that infected more than 8000 individuals and resulted in more than 800 fatalities in 2003. Currently, there is no effective treatment for this epidemic. SARS-3CLpro has been shown to be essential for replication and is thus a target for drug discovery. Here, a class of stable benzotriazole esters was reported as mechanism-based inactivators of 3CLpro, and the most potent inactivator exhibited a kinact of 0.0011 s−1 and a Ki of 7.5 nM. Mechanistic investigation with kinetic and mass spectrometry analyses indicates that the active site Cys145 is acylated, and that no irreversible inactivation was observed with the use of the C145A mutant. In addition, a noncovalent, competitive inhibition became apparent by using benzotriazole ester surrogates in which the bridged ester-oxygen group is replaced with carbon.
Co-reporter:Masakazu Sugiyama;Zhangyong Hong;Lisa J. Whalen;William A. Greenberg
Advanced Synthesis & Catalysis 2006 Volume 348(Issue 18) pp:
Publication Date(Web):15 DEC 2006
DOI:10.1002/adsc.200600356

Dihydroxyacetone phosphate (DHAP)-dependent aldolases have been widely used for the organic synthesis of unnatural sugars or derivatives. The practicality of using DHAP-dependent aldolases is limited by their strict substrate specificity and the high cost and instability of DHAP. Here we report that the DHAP-dependent aldolase L-rhamnulose 1-phosphate aldolase (RhaD) accepts dihydroxyacetone (DHA) as a donor substrate in the presence of borate buffer, presumably by reversible in situ formation of DHA borate ester. The reaction appears to be irreversible, with the products thermodynamically trapped as borate complexes. We have applied this discovery to develop a practical one-step synthesis of the non-caloric sweetener L-fructose. L-Fructose was synthesized from racemic glyceraldehyde and DHA in the presence of RhaD and borate in 92 % yield on a gram scale. We also synthesized a series of L-iminocyclitols, which are potential glycosidase inhibitors, in only two steps.

Co-reporter:Ashraf Brik, Chung-Yi Wu and Chi-Huey Wong  
Organic & Biomolecular Chemistry 2006 vol. 4(Issue 8) pp:1446-1457
Publication Date(Web):22 Mar 2006
DOI:10.1039/B600055J
The use of libraries extracted from nature or constructed by combinatorial chemistry, have been widely appreciated in the drug discovery area. In this perspective, we present our contribution to the field of enzyme inhibitor discovery using a useful approach that allows diversification of a common core in a microtiter plate followed by in situ screening. Our method relies on an organic reaction that is highly selective, high yielding, amenable to the microscale and preferably can be performed in water. The core can be a designed molecule based on the structural and mechanistic information of the target, a compound with a weak binding affinity, or a natural product. Several reactions were found useful for this approach and were applied to the rapid discovery of potent inhibitors of representative enzymes.
Co-reporter:Zhangyong Hong Dr.;Lei Liu Dr.;Che-Chang Hsu Dr.
Angewandte Chemie International Edition 2006 Volume 45(Issue 44) pp:
Publication Date(Web):10 OCT 2006
DOI:10.1002/anie.200601555

Flexible yet efficient: Sialic acids such as L-N-acetylneuraminic acid (see picture) can be synthesized in only three steps by 1) vinylation of an aldose through a modified Petasis coupling reaction, 2) 1,3-dipolar cycloaddition with a nitrone to construct an isoxazolidine ring, and 3) base-catalyzed β elimination/ring opening of the isoxazolidine to generate a γ-hydroxy-α-keto acid.

Co-reporter:Pi-Hui Liang Dr.;Wei-Chieh Cheng Dr.;Yi-Ling Lee;Han-Pang Yu;Ying-Ta Wu Dr.;Yi-Ling Lin Dr.
ChemBioChem 2006 Volume 7(Issue 1) pp:
Publication Date(Web):5 JAN 2006
DOI:10.1002/cbic.200500321

A novel 5-membered iminocyclitol derivative was found to be a potent and selective inhibitor of the glycoprotein-processing α-glucosidase with a Kivalue of 53 nM. This compound was further derivatized to antiviral agents against Japanese encephalitis virus, dengue virus serotype 2 (DEN-2), human SARS coronavirus, and human β-hexosaminidase (Ki=2.6 nM), a new target for the development of osteoarthritis therapeutics.

Co-reporter:Lei Liu Dr.;Zhang-Yong Hong Dr.
ChemBioChem 2006 Volume 7(Issue 3) pp:
Publication Date(Web):30 JAN 2006
DOI:10.1002/cbic.200500437

Without a trace. An approach combining traceless Staudinger ligation and protease-catalyzed N-terminal azidonation has been shown to be efficient for the convergent synthesis of glycopeptides without the cysteine limitation of native chemical ligation.

Co-reporter:Masaaki Sawa;Tsui-Ling Hsu;Takeshi Itoh;Masakazu Sugiyama;Peter K. Vogt;Sarah R. Hanson
PNAS 2006 Volume 103 (Issue 33 ) pp:12371-12376
Publication Date(Web):2006-08-15
DOI:10.1073/pnas.0605418103
Glycomics is emerging as a new field for the biology of complex glycoproteins and glycoconjugates. The lack of versatile glycan-labeling methods has presented a major obstacle to visualizing at the cellular level and studying glycoconjugates. To address this issue, we developed a fluorescent labeling technique based on the Cu(I)-catalyzed [3 + 2] cycloaddition, or click chemistry, which allows rapid, versatile, and specific covalent labeling of cellular glycans bearing azide groups. The method entails generating a fluorescent probe from a nonfluorescent precursor, 4-ethynyl-N-ethyl-1,8-naphthalimide, by clicking the fluorescent trigger, the alkyne at the 4 position, with an azido-modified sugar. Using this click-activated fluorescent probe, we demonstrate incorporation of an azido-containing fucose analog into glycoproteins via the fucose salvage pathway. Distinct fluorescent signals were observed by flow cytometry when cells treated with 6-azidofucose were labeled with the click-activated fluorogenic probe or biotinylated alkyne. The intracellular localization of fucosylated glycoconjugates was visualized by using fluorescence microscopy. This technique will allow dynamic imaging of cellular fucosylation and facilitate studies of fucosylated glycoproteins and glycolipids.
Co-reporter:Fu-Sen Liang;William A. Greenberg;Jennifer A. Hammond;Julia Hoffmann;Steven R. Head
PNAS 2006 Volume 103 (Issue 33 ) pp:12311-12316
Publication Date(Web):
DOI:10.1073/pnas.0605264103
Co-reporter:Douglass Wu;Masakazu Fujio;Dirk M. Zajonc;Mitchell Kronenberg;Barbara A. Sullivan;Yuki Kinjo;Ian A. Wilson
PNAS 2006 Volume 103 (Issue 11 ) pp:3972-3977
Publication Date(Web):2006-03-14
DOI:10.1073/pnas.0600285103
Natural killer T (NKT) cells provide an innate-type immune response upon T cell receptor interaction with CD1d-presented antigens. We demonstrate through equilibrium tetramer binding and antigen presentation assays with Vα14i-positive NKT cell hybridomas that the Sphingomonas glycolipid α-galacturonosyl ceramide (GalA-GSL) is a NKT cell agonist that is significantly weaker than α-galactosylceramide (α-GalCer), the most potent known NKT agonist. For GalA-GSL, a shorter fatty acyl chain, an absence of the 4-OH on the sphingosine tail and a 6′-COOH group on the galactose moiety account for its observed antigenic potency. We further determined the crystal structure of mCD1d in complex with GalA-GSL at 1.8-Å resolution. The overall binding mode of GalA-GSL to mCD1d is similar to that of the short-chain α-GalCer ligand PBS-25, but its sphinganine chain is more deeply inserted into the F′ pocket due to alternate hydrogen-bonding interactions between the sphinganine 3-OH with Asp-80. Subsequently, a slight lateral shift (>1 Å) of the galacturonosyl head group is noted at the CD1 surface compared with the galactose of α-GalCer. Because the relatively short C14 fatty acid of GalA-GSL does not fully occupy the A′ pocket, a spacer lipid is found that stabilizes this pocket. The lipid spacer was identified by GC/MS as a mixture of saturated and monounsaturated palmitic acid (C16). Comparison of available crystal structures of α-anomeric glycosphingolipids now sheds light on the structural basis of their differential antigenic potency and has led to the design and synthesis of NKT cell agonists with enhanced cell-based stimulatory activities compared with α-GalCer.
Co-reporter:Wan-Lin Lo;Ming-Hong Chuang;Ming-Shiang Wu;Jaw-Town Lin;Shyh-Horng Chiou
PNAS 2006 Volume 103 (Issue 8 ) pp:2552-2557
Publication Date(Web):2006-02-21
DOI:10.1073/pnas.0510770103
Helicobacter pylori, an oxygen-sensitive microaerophilic bacterium, contains many antioxidant proteins, among which alkylhydroperoxide reductase (AhpC) is the most abundant. The function of AhpC is to protect H. pylori from a hyperoxidative environment by reduction of toxic organic hydroperoxides. We have found that the sequence of AhpC from H. pylori is more homologous to mammalian peroxiredoxins than to eubacterial AhpC. We have also found that the protein structure of AhpC could shift from low-molecular-weight oligomers with peroxide-reductase activity to high-molecular-weight complexes with molecular-chaperone function under oxidative stresses. Time-course study by following the quaternary structural change of AhpC in vivo revealed that this enzyme changes from low-molecular-weight oligomers under normal microaerobic conditions or short-term oxidative shock to high-molecular-weight complexes after severe long-term oxidative stress. This study revealed that AhpC of H. pylori acts as a peroxide reductase in reducing organic hydroperoxides and as a molecular chaperone for prevention of protein misfolding under oxidative stress.
Co-reporter:Steve Head;Desiree A. Thayer;Julia Hoffmann;Michael D. Best;Cheng-Yuan Huang;Aileen Y. Chang
PNAS 2006 Volume 103 (Issue 1 ) pp:15-20
Publication Date(Web):2006-01-03
DOI:10.1073/pnas.0509693102
Understanding the specificity of cell-surface carbohydrates interaction with antibodies and receptors is important for the development of new therapeutics and high-sensitivity diagnostics. This approach is, however, limited to the availability of natural and truncated sequences of the oligosaccharides and the sensitivity of the assay system. Reported here is the synthesis of the cancer antigen Globo H hexasaccharide, an epitope found on the cell surface of breast, prostate, and ovarian cancers, and its truncated sequences by using the programmable one-pot synthesis strategy. The saccharides were then arrayed covalently on glass slides with different density and used for the fluorencense-based binding analysis of two monoclonal antibodies against Globo H and the serum from breast cancer patients, to define the specificity of these antibodies. It was shown that the terminal tetrasaccharide binds the monoclonal antibodies equally well as does the hexasaccharide and the fucose residue is required for effective binding. The serum binds both the defucosylated pentasaccharide and the fucosylated hexasaccharide without a significant difference, perhaps because of the polyclonal nature of the serum or the presence of diverse immune responses to different sugar epitopes at various stages. This method requires very small amounts of materials and is more effective and sensitive than the traditional ELISA method, and thus provides another platform to monitor the immune response to carbohydrate epitopes at different stages during differentiation, metastasis, or treatment.
Co-reporter:Jinq-Chyi Lee Dr.;Chung-Yi Wu Dr.;Junefredo V. Apon;Gary Siuzdak
Angewandte Chemie 2006 Volume 118(Issue 17) pp:
Publication Date(Web):20 MAR 2006
DOI:10.1002/ange.200504067

Zuckersüße Synthese: Einfach zugängliche Thioglycoside mit definierten relativen Reaktivitätswerten dienten als Bausteine in einer Eintopfsynthese des tumorassoziierten Kohlenhydrat-N3-Nebenantigens (siehe Formel). Die Zielverbindung wurde für die direkte Charakterisierung durch Laserlicht-gestützte Massenspektrometrie über einen photospaltbaren Linker kovalent an eine poröse Siliciumoberfläche gebunden.

Co-reporter:Jinq-Chyi Lee Dr.;Chung-Yi Wu Dr.;Junefredo V. Apon;Gary Siuzdak
Angewandte Chemie International Edition 2006 Volume 45(Issue 17) pp:
Publication Date(Web):20 MAR 2006
DOI:10.1002/anie.200504067

Sweet and light: Readily available thioglycosides with defined relative reactivity values were used as building blocks in a one-pot strategy to synthesize the tumor-associated carbohydrate antigen N3 minor (1). The target molecule was attached covalently to a porous silicon surface through a photocleavable linker for direct characterization in a mass spectrometer equipped with a laser source.

Co-reporter:Chi-Huey Wong
Advanced Synthesis & Catalysis 2005 Volume 347(Issue 7-8) pp:
Publication Date(Web):1 JUN 2005
DOI:10.1002/adsc.200505112
Co-reporter:Guo-Wen Xing, Douglass Wu, Michael A. Poles, Amir Horowitz, Moriya Tsuji, David D. Ho, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2005 Volume 13(Issue 8) pp:2907-2916
Publication Date(Web):15 April 2005
DOI:10.1016/j.bmc.2005.02.018
Two novel hybrid molecules 3-O-sulfo-α/β-galactosylceramide 3 and 4, which are derived from an immunostimulatory agent α-GalCer 1 and self-glycolipid ligand sulfatide 2, were designed and synthesized. Compound 3 was shown to efficiently stimulate human NKT cells to secret IL-4 and IFN-γ, with activities similar to 1, suggesting that modification of the 3″-OH position of the galactose moiety with sulfate has no significant effect on NKT cell stimulation. As a comparison, the β-isomer 4 has no affinity to NKT cells, which demonstrates that the α-glycosidic bond of galactosylceramide is crucial to the NKT cells activation.
Co-reporter:Ashraf Brik Dr.;Jerry Alexratos;Ying-Chuan Lin Dr.;John H. Elder ;Arthur J. Olson ;Alexer Wlodawer Dr.;David S. Goodsell
ChemBioChem 2005 Volume 6(Issue 7) pp:
Publication Date(Web):3 JUN 2005
DOI:10.1002/cbic.200500101

Substitute for another bond. Docking simulations of two potent inhibitors that bear the 1,2,3-triazole moiety produced two conformations of approximately equal energy. Further analysis of the protease by X-ray crystallography solved the ambiguity of the binding mode and revealed that the triazole ring is an effective amide surrogate and retains all the hydrogen bonds in the active site (see figure).

Co-reporter:Desiree A. Thayer;Henry N. Yu Dr.;M. Carmen Galan Dr.
Angewandte Chemie 2005 Volume 117(Issue 29) pp:
Publication Date(Web):30 JUN 2005
DOI:10.1002/ange.200500090

Eine effiziente Eintopfsynthese von S-verknüpften Glycosylaminosäuren 1 wurde entwickelt (siehe Schema; DMF=Dimethylformamid) und in der Festphasensynthese von S-verknüpften Glycopeptiden genutzt. Dieser Ansatz ermöglichte die Synthese einer Vielzahl S-verknüpfter Glycosylaminosäure-Bausteine in hoher Ausbeute.

Co-reporter:Chung-Yi Wu Dr.;Ashraf Brik Dr.;Sheng-Kai Wang;Yu-Hsien Chen
ChemBioChem 2005 Volume 6(Issue 12) pp:
Publication Date(Web):4 NOV 2005
DOI:10.1002/cbic.200500295

No isolation, no purification. An efficient and simple method based on tetrabutylammonium fluoride-mediated alkylation without protecting groups in microtiter plates, followed by screening in situ has been developed to identify new enzyme inhibitors, as demonstrated in the discovery of the shown potent inhibitors of cathepsin B and HIV protease.

Co-reporter:Mehdi M. D. Numa Dr.;Lac V. Lee Dr.;Che-Chang Hsu Dr.;Kristen E. Bower Dr.
ChemBioChem 2005 Volume 6(Issue 6) pp:
Publication Date(Web):6 MAY 2005
DOI:10.1002/cbic.200500009

Potent library. Anthrax lethal factor (LF) is a zinc-dependent metalloprotease involved in the rapid development of the deadly infection caused by Bacillus anthracis. Blocking its action is a plausible method to mitigate the deleterious effects of late stage infection. We report the inhibition of LF by tetrahydro-isoquinoline polyphenolic compounds, such as 5 a, which were identified by screening a combinatorial library that was generated by Pictet–Spengler reaction. We also report the identification of commercially available polyphenolic inhibitors against LF.

Co-reporter:Paul T. Nyffeler;Sergio Gonzalez Durón Dr.;Michael D. Burkart Dr.;Stéphane P. Vincent Dr.
Angewandte Chemie International Edition 2005 Volume 44(Issue 2) pp:
Publication Date(Web):1 DEC 2004
DOI:10.1002/anie.200400648

The replacement of hydrogen atoms with fluorine substituents in organic substrates is of great interest in synthetic chemistry because of the strong electronegativity of fluorine and relatively small steric footprint of fluorine atoms. Many sources of nucleophilic fluorine are available for the derivatization of organic molecules under acidic, basic, and neutral conditions. However, electrophilic fluorination has historically required molecular fluorine, whose notorious toxicity and explosive tendencies limit its application in research. The necessity for an electrophilic fluorination reagent that is safe, stable, highly reactive, and amenable to industrial production as an alternative to very hazardous molecular fluorine was the inspiration for the discovery of selectfluor. This reagent is not only one of the most reactive electrophilic fluorinating reagents available, but it is also safe, nontoxic, and easy to handle. In this Review we document the many applications of selectfluor and discuss possible mechanistic pathways for its reaction.

Co-reporter:Paul T. Nyffeler;Sergio Gonzalez Durón Dr.;Michael D. Burkart Dr.;Stéphane P. Vincent Dr.
Angewandte Chemie 2005 Volume 117(Issue 2) pp:
Publication Date(Web):1 DEC 2004
DOI:10.1002/ange.200400648

Der Ersatz von Wasserstoff durch Fluor in organischen Substraten ist wegen der hohen Elektronegativität des Fluors bei fast gleich bleibendem Raumanspruch von großem Interesse in der Synthesechemie. Viele Quellen für nucleophiles Fluor zur Derivatisierung unter sauren, basischen und neutralen Bedingungen stehen zur Verfügung. Hingegen erforderte eine elektrophile Fluorierung früher den Einsatz von molekularem Fluor, was aufgrund dessen Toxizität und Explosionsneigung zu einer nur begrenzten Anwendung dieser Methode geführt hat. Der Bedarf an einem elektrophilen Fluorierungsreagens, das sicher zu handhaben, stabil und hoch reaktiv ist und in der industriellen Produktion als Alternative zum hoch giftigen gasförmigen Fluor eingesetzt werden kann, führte letztlich zur Entwicklung von Selectfluor (1). Dieses Reagens ist eines der reaktivsten elektrophilen Fluorierungsmittel und dazu noch ungefährlich, nicht toxisch und leicht zu handhaben. In diesem Aufsatz beschreiben wir die zahlreichen Einsatzmöglichkeiten von Selectfluor und diskutieren mögliche Reaktionsmechanismen.

Co-reporter:Daniel A. Calarese;Hing-Ken Lee;Cheng-Yuan Huang;Michael D. Best;Rena D. Astronomo;Robyn L. Stanfield;Hermann Katinger;Dennis R. Burton;Ian A. Wilson
PNAS 2005 102 (38 ) pp:13372-13377
Publication Date(Web):2005-09-20
DOI:10.1073/pnas.0505763102
Human antibody 2G12 neutralizes a broad range of HIV-1 isolates. Hence, molecular characterization of its epitope, which corresponds to a conserved cluster of oligomannoses on the viral envelope glycoprotein gp120, is a high priority in HIV vaccine design. A prior crystal structure of 2G12 in complex with Man9GlcNAc2 highlighted the central importance of the D1 arm in antibody binding. To characterize the specificity of 2G12 more precisely, we performed solution-phase ELISA, carbohydrate microarray analysis, and cocrystallized Fab 2G12 with four different oligomannose derivatives (Man4, Man5, Man7, and Man8) that compete with gp120 for binding to 2G12. Our combined studies reveal that 2G12 is capable of binding both the D1 and D3 arms of the Man9GlcNAc2 moiety, which would provide more flexibility to make the required multivalent interactions between the antibody and the gp120 oligomannose cluster than thought previously. These results have important consequences for the design of immunogens to elicit 2G12-like neutralizing antibodies as a component of an HIV vaccine.
Co-reporter:Daniel A. Calarese;Hing-Ken Lee;Cheng-Yuan Huang;Michael D. Best;Rena D. Astronomo;Robyn L. Stanfield;Hermann Katinger;Dennis R. Burton;Ian A. Wilson
PNAS 2005 102 (38 ) pp:13372-13377
Publication Date(Web):2005-09-20
DOI:10.1073/pnas.0505763102
Human antibody 2G12 neutralizes a broad range of HIV-1 isolates. Hence, molecular characterization of its epitope, which corresponds to a conserved cluster of oligomannoses on the viral envelope glycoprotein gp120, is a high priority in HIV vaccine design. A prior crystal structure of 2G12 in complex with Man9GlcNAc2 highlighted the central importance of the D1 arm in antibody binding. To characterize the specificity of 2G12 more precisely, we performed solution-phase ELISA, carbohydrate microarray analysis, and cocrystallized Fab 2G12 with four different oligomannose derivatives (Man4, Man5, Man7, and Man8) that compete with gp120 for binding to 2G12. Our combined studies reveal that 2G12 is capable of binding both the D1 and D3 arms of the Man9GlcNAc2 moiety, which would provide more flexibility to make the required multivalent interactions between the antibody and the gp120 oligomannose cluster than thought previously. These results have important consequences for the design of immunogens to elicit 2G12-like neutralizing antibodies as a component of an HIV vaccine.
Co-reporter:Che-Chang Hsu;Zhangyong Hong;Masaru Wada;Dirk Franke
PNAS 2005 102 (26 ) pp:9122-9126
Publication Date(Web):2005-06-28
DOI:10.1073/pnas.0504033102
An efficient l-3-deoxy-manno-2-octulosonic acid (l-KDO) aldolase was created by directed evolution from the Escherichia coli d-Neu5Ac (N-acetylneuraminic acid, d-sialic acid) aldolase. Five rounds of error-prone PCR and iterative screening were performed with sampling of 103 colonies per round. The specificity constant (k cat/K m) of the unnatural sugar l-KDO is improved to a level equivalent to the wild-type d-sialic acid aldolase for its natural substrate, d-Neu5Ac. The final evolved enzyme exhibits a >1,000-fold improved ratio of the specificity constant [k cat/K m (l-KDO)]/[k cat/K m (d-sialic acid)]. The protein sequence of the evolved aldolase showed eight amino acid changes from the native enzyme, with all of the observed changes occurring outside of the active site. Our effort demonstrates that an enzyme can be rapidly altered to accept enantiomeric substrates with screening of a small population of colonies iteratively toward the target substrate with improved catalytic efficiency. This work provides a method for the synthesis of enantiomeric sugars and for the study of enantiomeric catalysis affected by remote mutations.
Co-reporter:Douglass Wu;Guo-Wen Xing;Michael A. Poles;Amir Horowitz;Yuki Kinjo;Barbara Sullivan;Vera Bodmer-Narkevitch;Oliver Plettenburg;Mitchell Kronenberg;Moriya Tsuji;David D. Ho;
Proceedings of the National Academy of Sciences 2005 102(5) pp:1351-1356
Publication Date(Web):January 21, 2005
DOI:10.1073/pnas.0408696102
The CD1 family of proteins binds self and foreign glycolipids for presentation to CD1-restricted T cells. To identify previously uncharacterized active CD1 ligands, especially those of microbial origin, numerous glycolipids were synthesized and tested for their ability to stimulate mouse and human natural killer T (NKT) cells. They included analogs of the well known NKT cell agonist α-galactosyl ceramide (α-GalCer), bacterial glycolipids, and variations of the self-glycolipid, sulfatide. Bacterial glycolipids, α-galacturonosyl-ceramides from Sphingomonas wittichii, although structurally similar to α-GalCer, have significant differences in the sugar head group as well as the ceramide portion. The Sphingomonas glycosphingolipids (GSLs) and sulfatide variants were shown to activate human NKT cells as measured by IL-4 and IFN-γ secretion. Moreover, CD1d-dimer staining revealed human NKT cell reactivity toward these GSLs and to the sulfatides in a fashion comparable with α-GalCer. Because α-GalCer is a marine-sponge-derived ligand, our study here shows that bacterium-derived antigens are also able to stimulate mouse and human NKT cells.
Co-reporter:Desiree A. Thayer;Henry N. Yu Dr.;M. Carmen Galan Dr.
Angewandte Chemie International Edition 2005 Volume 44(Issue 29) pp:
Publication Date(Web):30 JUN 2005
DOI:10.1002/anie.200500090

A high-yield one-pot synthesis of S-linked glycosyl amino acids 1 has been developed (see scheme; DMF=dimethyl formamide) and used in the solid-phase synthesis of S-linked glycopeptides. This approach has been shown to be efficient for the synthesis of various S-linked glycosyl amino acid building blocks.

Co-reporter:Micha Fridman;Valery Belakhov Dr.;Lac V. Lee Dr.;Fu-Sen Liang Dr. Dr.;Timor Baasov Dr.
Angewandte Chemie International Edition 2005 Volume 44(Issue 3) pp:
Publication Date(Web):29 DEC 2004
DOI:10.1002/anie.200462003

Defence against bioterrorism: Recent events have created an urgent need for therapeutic strategies to treat anthrax, an infectious disease caused by the toxigenic bacterium Bacillus anthracis. A new class of aminoglycosides (see picture) are powerful inhibitors under physiological conditions of the anthrax lethal factor, which has a major role in the disease, and function simultaneously as antibiotics against B. anthracis.

Co-reporter:Sarah R. Hanson;Michael D. Best Dr.
Angewandte Chemie International Edition 2004 Volume 43(Issue 43) pp:
Publication Date(Web):18 OCT 2004
DOI:10.1002/anie.200300632

Sulfatases, which cleave sulfate esters in biological systems, play a key role in regulating the sulfation states that determine the function of many physiological molecules. Sulfatase substrates range from small cytosolic steroids, such as estrogen sulfate, to complex cell-surface carbohydrates, such as the glycosaminoglycans. The transformation of these molecules has been linked with important cellular functions, including hormone regulation, cellular degradation, and modulation of signaling pathways. Sulfatases have also been implicated in the onset of various pathophysiological conditions, including hormone-dependent cancers, lysosomal storage disorders, developmental abnormalities, and bacterial pathogenesis. These findings have increased interest in sulfatases and in targeting them for therapeutic endeavors. Although numerous sulfatases have been identified, the wide scope of their biological activity is only beginning to emerge. Herein, accounts of the diversity and growing biological relevance of sulfatases are provided along with an overview of the current understanding of sulfatase structure, mechanism, and inhibition.

Co-reporter:Hing-Ken Lee Dr.;Christopher N. Scanlan;Cheng-Yuan Huang;Aileen Y. Chang Dr.;Daniel A. Calarese;Raymond A. Dwek Dr.;Pauline M. Rudd Dr.;Dennis R. Burton Dr.;Ian. A. Wilson Dr. Dr.
Angewandte Chemie International Edition 2004 Volume 43(Issue 8) pp:
Publication Date(Web):11 FEB 2004
DOI:10.1002/anie.200353105

An HIV-1 vaccine may eventually be developed from oligomannoses synthesized by a reactivity-based one-pot self-condensation strategy. The compounds were tested for their ability to inhibit the binding of gp120 to the broadly neutralizing HIV-1 antibody 2G12. New epitope mimics (see structure for example) were identified that inhibit this binding as well as, or better than the natural epitope Man9GlcNAc2 (Man=mannose, Glc=glucose).

Co-reporter:Fu-Sen Liang;Sheng-Kai Wang;Takuji Nakatani Dr.
Angewandte Chemie International Edition 2004 Volume 43(Issue 47) pp:
Publication Date(Web):1 DEC 2004
DOI:10.1002/anie.200460558

A library of 4,6-linked analogues of the drug tobramycin with various mono- or diaminosugars attached to the 6-position of the two-ring core has been prepared (see scheme; Bn=benzyl, Tol=p-tolyl). The compounds were screened against different disease-related RNAs, and several of the synthetic analogues showed a high affinity and selectivity toward certain RNA sequences.

Co-reporter:Fu-Sen Liang;Sheng-Kai Wang;Takuji Nakatani Dr.
Angewandte Chemie 2004 Volume 116(Issue 47) pp:
Publication Date(Web):1 DEC 2004
DOI:10.1002/ange.200460558

Eine Bibliothek 4,6-verknüpfter Analoga von Tobramycin mit Mono- oder Diaminozuckern an der 6-Position des Zweiringkerns wurde hergestellt (siehe Schema). Ein Screening der Verbindungen gegen mehrere zu Krankheiten in Beziehung stehende RNAs ergab eine hohe Affinität und Selektivität einiger der synthetischen Analoga für bestimmte RNA-Sequenzen.

Co-reporter:Michael D. Best Dr.;Ashraf Brik Dr.;Eli Chapman Dr.;Lac V. Lee Dr.;Wei-Chieh Cheng Dr.
ChemBioChem 2004 Volume 5(Issue 6) pp:
Publication Date(Web):26 MAY 2004
DOI:10.1002/cbic.200300841

Rapid diversity-oriented microplate library synthesis and in situ screening with a high-throughput fluorescence-based assay were used to develop potent inhibitors of β-arylsulfotransferase IV (β-AST-IV). This strategy leads to facile inhibitor synthesis and study as it allows protecting-group manipulation and product isolation from other library components to be avoided. Through repeated library formation, three aspects of inhibitor makeup, the identities of the two binding groups and the length of the linker between them, were independently optimized. Several potent inhibitors were obtained, one of which was determined to have an inhibition constant Kiof 5 nM. This compound is the most potent β-AST-IV inhibitor developed to date, with a Kivalue more than five orders of magnitude lower than the Michaelis constant Kmfor the substrate whose binding it inhibits.

Co-reporter:Fabio Agnelli Dr.;Steven J. Sucheck Dr.;Kenneth A. Marby;David Rabuka;Su-Lan Yao Dr.;Pamela S. Sears Dr.;Fu-Sen Liang
Angewandte Chemie 2004 Volume 116(Issue 12) pp:
Publication Date(Web):9 MAR 2004
DOI:10.1002/ange.200353225

Doppeltes Spiel: Dimere Aminoglycosid-Antibiotika wurden durch Verknüpfung von Neamin- oder Nebramin-Kernen mit Linkern unterschiedlicher Länge und Zusammensetzung erhalten. Die Dimere zeigen hohe Affinität zum 16S-A-Zentrum ribosomaler RNA (siehe Schema) und wirken effektiv gegen mehrere aminoglycosidresistente Bakterienstämme.

Co-reporter:Sarah R. Hanson;Michael D. Best Dr.
Angewandte Chemie 2004 Volume 116(Issue 43) pp:
Publication Date(Web):18 OCT 2004
DOI:10.1002/ange.200300632

Sulfatasen – d. h. Sulfatester spaltende Enzyme – spielen eine entscheidende Rolle bei der Regulierung von Sulfatierungszuständen, die über die Funktion vieler physiologischer Moleküle entscheiden. Die Substrate der Sulfatasen reichen von kleinen cytosolischen Steroiden wie dem Östrogensulfat bis hin zu komplexen Kohlenhydraten auf Zelloberflächen, etwa den Glycosaminoglycanen. Die Umwandlung dieser Moleküle wurde mit wichtigen zellulären Funktionen in Verbindung gebracht, z. B. mit der Hormonregulation, dem zellulären Abbau und der Modulation von Signalisierungsprozessen. Sulfatasen hängen mit dem Ausbruch etlicher pathophysiologischer Erscheinungen zusammen, etwa mit hormonabhängigen Krebsformen. Bis heute sind zwar zahlreiche Sulfatasen identifiziert worden, die Aufklärung des weitreichenden Spektrums ihrer biologischen Aktivitäten befindet sich aber erst am Anfang. Dieser Aufsatz gibt einen Überblick über den derzeitigen Wissensstand zu den Strukturen, Mechanismen und der Inhibition von Sulfatasen.

Co-reporter:Eli Chapman Dr.;Michael D. Best Dr.;Sarah R. Hanson
Angewandte Chemie 2004 Volume 116(Issue 27) pp:
Publication Date(Web):21 JUN 2004
DOI:10.1002/ange.200300631

Seit langem ist bekannt, dass die Sulfonierung von Biomolekülen in einer Vielzahl von Organismen stattfindet, von Prokaryoten bis hin zu vielzelligen Spezies, und ständig werden neue biologische Funktionen entdeckt, die mit dieser Umsetzung verknüpft sind. Frühe Studien zu Sulfotransferasen (STs), den Enzymen, die Sulfonierungen katalysieren, konzentrierten sich primär auf zytosolische STs, die an Entgiftungsreaktionen, der Hormonregulation und am Wirkstoffmetabolismus beteiligt sind. Obwohl man von ihrer Existenz gewusst hat, wurden membranassoziierte STs bis vor kurzem kaum untersucht. Sie sind an der Sulfonierung komplexer Kohlenhydrate und Proteine beteiligt und spielen eine zentrale Rolle bei einer Reihe von molekularen Erkennungsmechanismen und biochemischen Signalwegen. Des Weiteren hängen STs mit vielen pathophysiologischen Prozessen zusammen. Dies führte zu einem verstärkten Interesse an den komplexen Funktionen von STs und an der Möglichkeit zur Targetierung in therapeutischen Eingriffen. In diesem Aufsatz werden die Fortschritte bei der Aufklärung der Strukturen und Mechanismen von Sulfotransferasen sowie ihre biologische Aktivität, Inhibierung und Anwendung in der Synthese diskutiert.

Co-reporter:Eli Chapman Dr.;Michael D. Best Dr.;Sarah R. Hanson
Angewandte Chemie International Edition 2004 Volume 43(Issue 27) pp:
Publication Date(Web):21 JUN 2004
DOI:10.1002/anie.200300631

The sulfonation (also known as sulfurylation) of biomolecules has long been known to take place in a variety of organisms, from prokaryotes to multicellular species, and new biological functions continue to be uncovered in connection with this important transformation. Early studies of sulfotransferases (STs), the enzymes that catalyze sulfonation, focused primarily on the cytosolic STs, which are involved in detoxification, hormone regulation, and drug metabolism. Although known to exist, the membrane-associated STs were not studied as extensively until more recently. Involved in the sulfonation of complex carbohydrates and proteins, they have emerged as central players in a number of molecular-recognition events and biochemical signaling pathways. STs have also been implicated in many pathophysiological processes. As a result, much interest in the complex roles of STs and in their targeting for therapeutic intervention has been generated. Progress in the elucidation of the structures and mechanisms of sulfotransferases, as well as their biological activity, inhibition, and synthetic utility, are discussed in this Review.

Co-reporter:Fabio Agnelli Dr.;Steven J. Sucheck Dr.;Kenneth A. Marby;David Rabuka;Su-Lan Yao Dr.;Pamela S. Sears Dr.;Fu-Sen Liang
Angewandte Chemie International Edition 2004 Volume 43(Issue 12) pp:
Publication Date(Web):9 MAR 2004
DOI:10.1002/anie.200353225

Double duty: Dimeric aminoglycoside antibiotics were designed by linking neamine or nebramine cores with various tethers differing in length and composition. The resulting dimeric aminoglycosides displayed high affinity for the 16S A site of ribosomal RNA (a representation of the complex is shown here) and were effective against various aminoglycoside-resistant bacterial strains.

Co-reporter:Chi-Huey Wong
Advanced Synthesis & Catalysis 2003 Volume 345(Issue 6-7) pp:
Publication Date(Web):3 JUN 2003
DOI:10.1002/adsc.200303062
Co-reporter:Grace DeSantis, Junjie Liu, David P Clark, Andreas Heine, Ian A Wilson, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2003 Volume 11(Issue 1) pp:43-52
Publication Date(Web):2 January 2003
DOI:10.1016/S0968-0896(02)00429-7
2-Deoxyribose-5-phosphate aldolase (DERA, EC 4.1.2.4) catalyzes the reversible aldol reaction between acetaldehyde and d-glyceraldehyde-3-phosphate to generate d-2-deoxyribose-5-phosphate. It is unique among the aldolases as it catalyzes the reversible asymmetric aldol addition reaction of two aldehydes. In order to expand the substrate scope and stereoselectivity of DERA, structure-based substrate design as well as site-specific mutation has been investigated. Using the 1.05 Å crystal structure of DERA in complex with its natural substrate as a guide, five site-directed mutants were designed in order to improve its activity with the unnatural nonphosphorylated substrate, d-2-deoxyribose. Of these, the S238D variant exhibited a 2.5-fold improvement over the wild-type enzyme in the retroaldol reaction of 2-deoxyribose. Interestingly, this S238D mutant enzyme was shown to accept 3-azidopropinaldehyde as a substrate in a sequential asymmetric aldol reaction to form a deoxy-azidoethyl pyranose, which is a precursor to the corresponding lactone and the cholesterol-lowering agent Lipitor™. This azidoaldehyde is not a substrate for the wild-type enzyme. Another structure-based design of new nonphosphorylated substrates was focused on the aldol reaction with inversion in enantioselectivity using the wild type or the S238D variant as the catalyst and 2-methyl-substituted aldehydes as substrates. An example was demonstrated in the asymmetric synthesis of a deoxypyranose as a new effective synthon for the total synthesis of epothilones. In addition, to facilitate the discovery of new enzymatic reactions, the engineered E. coli strain SELECT (Δace, adhC, DE3) was developed to be used in the future for selection of DERA variants with novel nonphosphorylated acceptor specificity.Graphic
Co-reporter:Masaru Wada, Che-Chang Hsu, Dirk Franke, Michael Mitchell, Andreas Heine, Ian Wilson, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2003 Volume 11(Issue 9) pp:2091-2098
Publication Date(Web):1 May 2003
DOI:10.1016/S0968-0896(03)00052-X
Expanding the scope of substrate specificity and stereoselectivity is of current interest in enzyme catalysis. Using error-prone PCR for in vitro directed evolution, the Neu5Ac aldolase from Escherichia coli has been altered to improve its catalytic activity toward enantiomeric substrates including N-acetyl-l-mannosamine and l-arabinose to produce l-sialic acid and l-KDO, the mirror-image sugars of the corresponding naturally occurring d-sugars. The first generation variant containing two mutations (Tyr98His and Phe115Leu) outside the (α,β)8-barrel active site exhibits an inversion of enantioselectivity toward KDO and the second generation variant contains an additional amino acid change Val251Ile outside the α,β-barrel active site that improves the enantiomeric formation of l-sialic acid and l-KDO. The X-ray structure of the triple mutant epNanA.2.5 at 2.3 Å resolution showed no significant difference between the wild-type and the mutant enzymes. We probed the potential structural ‘hot spot’ of enantioselectivity with saturation mutagenesis at Val251, the mutated residue most proximal to the Schiff base forming Lys165. The selected variant had an increase in kcat via replacement with another hydrophobic residue, leucine. Further sampling of a larger sequence space with error-prone PCR selected a third generation variant with significant improvement in l-KDO catalysis and a complete reversal of enantioselectivity.Graphic
Co-reporter:Chi Ching Mak, Ashraf Brik, Danica L Lerner, John H Elder, Garrett M Morris, Arthur J Olson, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2003 Volume 11(Issue 9) pp:2025-2040
Publication Date(Web):1 May 2003
DOI:10.1016/S0968-0896(03)00054-3
Based on the substrate transition state and our strategy to tackle the problem of drug resistance, a series of HIV/FIV protease (HIV /FIV PR) monocyclic inhibitors incorporating a 15- or 17-membered macrocycle with an equivalent P3 or P3′ group and a unique unnatural amino acid, (2R, 3S)-3-amino-2-hydroxy-4-phenylbutyric acid, have been designed and synthesized. In addition, based on the structure of TL3 with small P3/P3′ group, we have synthesized two conformationally restricted bicyclic inhibitors containing the macrocycle, which mimic the P1/P1′-P3/P3′ tripeptide [Phe-Val-Ala] of TL3. We have found that the contribution of the macrocycle in our monocyclic inhibitors is important to the overall activity, but the ring size does not affect the activity to a significant extent. Several inhibitors that were developed in this work, exhibit low nanomolar inhibitory activity against the wild-type HIV/FIV PR and found to be highly effective against some drug-resistant as well as TL3-resistant mutants of HIV PRs. Compound 15, in particular, is the most effective cyclic inhibitor in hand to inhibit FIV replication in tissue culture at a concentration of 1.0 μg/mL (1.2 μM).Graphic
Co-reporter:Ashraf Brik Dr.;John Muldoon Dr.;Ying-Chuan Lin Dr.;John H. Elder ;David S. Goodsell ;Arthur J. Olson ;Valery V. Fokin ;K. Bary Sharpless
ChemBioChem 2003 Volume 4(Issue 11) pp:
Publication Date(Web):3 NOV 2003
DOI:10.1002/cbic.200300724

Click and go: By using click chemistry based on a new triazole forming reaction condition (see scheme), over 100 triazole compounds generated in microtiter plates from a core structure were screened for HIV protease inhibition in situ without product isolation. Potent inhibitors, active at nanomolar concentrations, against the wild type and drug resistant mutants were identified.

Co-reporter:Haitian Liu;Thomas K. Ritter;Reiko Sadamoto Dr.;Pamela S. Sears Dr.;Min Wu Dr.
ChemBioChem 2003 Volume 4(Issue 7) pp:
Publication Date(Web):27 JUN 2003
DOI:10.1002/cbic.200300557

A continuous fluorescence coupled enzyme assay was developed to study the acceptor specificity of the glycosyltransferase MurG toward different lipid I analogues with various substituents replacing the undecaprenyl moiety. It was found that most lipid I analogues are accepted as substrates and, amongst these, the saturated C14analogue exhibits the best activity. This substrate was used to evaluate the inhibition activity of such antibiotics as moenomycin, vancomycin, and two chlorobiphenyl vancomycin derivatives. A vancomycin derivative with a chlorobiphenyl moiety on the aglycon section was identified as a potent inhibitor of MurG.

Co-reporter:Thomas K. Ritter Dr.;Kwok-Kong T. Mong Dr.;Haitian Liu;Takuji Nakatani Dr. Dr.
Angewandte Chemie 2003 Volume 115(Issue 38) pp:
Publication Date(Web):1 OCT 2003
DOI:10.1002/ange.200351534

Die bekannt schwierige Glycosylierung von Vancomycin wurde in einem Eintopf-Prozess ausgeführt. Dazu wurde eine Vielzahl von Oligosacchariden synthetisiert und mit dem Aglycon von Vancomycin verknüpft (siehe Formel). Mithilfe dieser Verbindungsbibliothek wurde der Einfluss der Glycosylierung auf die antibiotische Aktivität getestet.

Co-reporter:Chung-Yi Wu Dr.;Chuan-Fa Chang Dr.;Jenny Szu-Yu Chen ;Chun-Hung Lin
Angewandte Chemie 2003 Volume 115(Issue 38) pp:
Publication Date(Web):1 OCT 2003
DOI:10.1002/ange.200351823

Eine effiziente und einfache Methode im Mikrotiterplattenformat zur Identifizierung potenter und selektiver Inhibitoren von α-Fucosidasen wurde entwickelt. Sie beruht auf der Amidbildung einer Fuconojirimycin-Kernstruktur mit Carbonsäuren und anschließendem Inhibierungs-Assay ohne Isolierung des Produkts. Gezeigt sind die Strukturen der beiden potentesten Inhibitoren.

Co-reporter:Tony K.-K. Mong Dr.;Lac V. Lee Dr.;Jillian R. Brown Dr.;Jeffrey D. Esko
ChemBioChem 2003 Volume 4(Issue 9) pp:
Publication Date(Web):4 SEP 2003
DOI:10.1002/cbic.200300650

Herein we describe an inhibition study of the sialyl Lewis x (sLex) expression on a human monocytic cell line (U937), using a series of peracetylated N-Acetyllactosamine (LacNAc) analogues with variation at the aglycon moiety. It was found that the extent of inhibition was related to the hydrophobicity and structure of the aglycon. In general, peracetylated LacNAc analogues with a naphthyl or biphenyl aglycon (3, 4, 6, and 7) were better in suppression of sLexexpression than a benzyl derivative (2). Steady-state kinetic experiments with humanα-1,3-fucosyltransferases IV and VI (FucT IV and VI, EC 2.4.1.65) revealed that the deacetylated LacNAc-aglycons with naphthyl (18, 19, and 20) or biphenyl (17) moieties exhibited higher affinity to the fucosyltransferases than aglycon moieties with smaller hydrophobic groups (14, 15, and 16). These results are in agreement with the findings of the U937 cell-based experiments, and suggest that the higher enzyme affinity LacNAc-aglycons make better acceptor decoys and, hence, the observed differences in LacNAc-aglycon inhihitory effects on sLexexpression.

Co-reporter:Eli Chapman;Marian C. Bryan
PNAS 2003 Volume 100 (Issue 3 ) pp:910-915
Publication Date(Web):2003-02-04
DOI:10.1073/pnas.0337638100
Sulfotransferases are an important class of enzymes that catalyze the transfer of a sulfuryl group to a hydroxyl or amine moiety on various molecules including small-molecule drugs, steroids, hormones, carbohydrates, and proteins. They have been implicated in a number of disease states but remain poorly understood, complicating the design of specific, small-molecule inhibitors. A linear free-energy analysis in both the forward and reverse directions indicates that the transfer of a sulfuryl group to an aryl hydroxyl group catalyzed by β-arylsulfotransferase IV likely proceeds by a dissociative (sulfotrioxide-like) mechanism. Values for the Brønsted coefficients (βnuc and βlg) are +0.33 and −0.45, giving Leffler α values of 0.19 and 0.61 for the forward and reverse reactions, respectively.
Co-reporter:Tony Kwok-Kong Mong;Hing-Ken Lee;Sergio G. Durón;
Proceedings of the National Academy of Sciences 2003 100(3) pp:797-802
Publication Date(Web):January 27, 2003
DOI:10.1073/pnas.0337590100
The total synthesis of the sialic acid-containing antigenic epitope fucose GM1 (Fuc-GM1) by an improved reactivity-based one-pot synthetic strategy is reported. Based on a thioglycoside reactivity database, three saccharide building blocks, 3, 4, and 5, were designed and prepared to incorporate a descending order of reactivity toward thiophilic activation. Using the reactivity-based one-pot synthetic method, the fully protected Fuc-GM1 glycoside 2 was furnished in a facile manner, which was globally deprotected to give the Fuc-GM1 glycoside 1. In addition, using the promoter system 1-(benzensulfinyl)piperidine/trifluoromethanesulfonic anhydride, the product yield was improved and the reaction time was reduced in comparison with the N-iodosuccinimide/trifluoromethanesulfonic acid- and dimethyl (thiomethyl) sulfonium trifluoromethanesulfonate-promoted systems.
Co-reporter:Chung-Yi Wu Dr.;Chuan-Fa Chang Dr.;Jenny Szu-Yu Chen ;Chun-Hung Lin
Angewandte Chemie International Edition 2003 Volume 42(Issue 38) pp:
Publication Date(Web):1 OCT 2003
DOI:10.1002/anie.200351823

An efficient and simple method has been developed to identify potent and selective inhibitors against α-fucosidases based on the amide-forming reaction in a microtiter plate of a fuconojirimycin core with various carboxylic acids, followed by a direct inhibition assay without product isolation. The structures of the two most potent inhibitors are shown.

Co-reporter:Thomas K. Ritter Dr.;Kwok-Kong T. Mong Dr.;Haitian Liu;Takuji Nakatani Dr. Dr.
Angewandte Chemie International Edition 2003 Volume 42(Issue 38) pp:
Publication Date(Web):1 OCT 2003
DOI:10.1002/anie.200351534

The notoriously difficult glycosylation of vancomycin was tackled in a one-pot procedure. A number of oligosaccharides were synthesized and attached to the vancomycin aglycon to create a library of derivatives (see formula) to probe the effect of glycosylation on the antibiotic activity.

Co-reporter:Yuan-Yuan Wang, Kay-Hooi Khoo, Shui-Tein Chen, Chun-Cheng Lin, Chi-Huey Wong, Chun-Hung Lin
Bioorganic & Medicinal Chemistry 2002 Volume 10(Issue 4) pp:1057-1062
Publication Date(Web):April 2002
DOI:10.1016/S0968-0896(01)00377-7
A fucose-containing glycoprotein fraction which stimulates spleen cell proliferation and cytokine expression has been identified from the water-soluble extract of Ganoderma lucidum. Proteomic analysis of mouse spleen cells treated with this glycoprotein fraction showed ∼50% change of the proteome. Further studies on the activities of this glycoprotein fraction through selective proteolysis and glycosidic cleavage indicate that a fucose containing polysaccharide fraction is responsible for stimulating the expression of cytokines, especially IL-1, IL-2 and INF-γ.Graphic
Co-reporter:Kwok-Kong T. Mong
Angewandte Chemie 2002 Volume 114(Issue 21) pp:
Publication Date(Web):31 OCT 2002
DOI:10.1002/1521-3757(20021104)114:21<4261::AID-ANGE4261>3.0.CO;2-3

Die stereospezifische Synthese des Kohlenhydrat-Haptens Lewis Y gelang durch eine Eintopfreaktion der drei Synthesebausteine 13, die anhand ihrer relativen Reaktivität (RR) für die Reaktion ausgewählt wurden.

Co-reporter:Thomas J. Tolbert Dr.
Angewandte Chemie International Edition 2002 Volume 41(Issue 12) pp:
Publication Date(Web):12 JUN 2002
DOI:10.1002/1521-3773(20020617)41:12<2171::AID-ANIE2171>3.0.CO;2-Q

The highly selective tobacco etch virus Nla protease (TEV protease) can be used to remove affinity tags with mutated cleavage sites to produce proteins for site-specific labeling and chemoselective ligations (see scheme). This provides a simple, efficient method for producing proteins with N-terminal cysteines for proteomic applications.

Co-reporter:Michael L. Mitchell Dr.;Feng Tian Dr.;Lac V. Lee Dr.
Angewandte Chemie International Edition 2002 Volume 41(Issue 16) pp:
Publication Date(Web):21 AUG 2002
DOI:10.1002/1521-3773(20020816)41:16<3041::AID-ANIE3041>3.0.CO;2-V

Mimics of the geometry or charge of the fucose moiety of GDP-fucose in the transition state of fucosyltransferase-catalyzed reactions, compounds 13 are good competive inhibitors of α-1,3-fucosyltransferases V and VI with Ki values between 6 and 13 μM. GDP=guanosine diphosphate.

Co-reporter:Kwok-Kong T. Mong
Angewandte Chemie International Edition 2002 Volume 41(Issue 21) pp:
Publication Date(Web):31 OCT 2002
DOI:10.1002/1521-3773(20021104)41:21<4087::AID-ANIE4087>3.0.CO;2-X

The stereospecific synthesis of a tumor-related carbohydrate antigenic hapten, Lewis Y, from three basic building units 13 has been achieved by a reactivity-based one-pot strategy. RRV=relative reactivity value.

Co-reporter:Junjie Liu Dr.
Angewandte Chemie 2002 Volume 114(Issue 8) pp:
Publication Date(Web):16 APR 2002
DOI:10.1002/1521-3757(20020415)114:8<1462::AID-ANGE1462>3.0.CO;2-0

Enzymatische Reaktionen mit DERA dienen als Grundlage für eine neue Strategie zur Synthese von Pyranosebausteinen. Die Nützlichkeit dieser hoch konvergenten und effektiven Methode wird am Beispiel einer kurzen Totalsynthese von Epothilonen gezeigt (siehe Schema; DERA=2-Desoxyribose-5-phosphataldolase).

Co-reporter:Junjie Liu Dr.
Angewandte Chemie International Edition 2002 Volume 41(Issue 8) pp:
Publication Date(Web):16 APR 2002
DOI:10.1002/1521-3773(20020415)41:8<1404::AID-ANIE1404>3.0.CO;2-G

Enzymatic reactions catalyzed by DERA provide the basis for a new strategy for the synthesis of novel pyranose synthons. The utility of this very convergent and effective method is demonstrated by the concise total synthesis of epothilones (see scheme; DERA=2-deoxyribose-5-phosphate aldolase).

Co-reporter:Michael L. Mitchell Dr.;Feng Tian Dr.;Lac V. Lee Dr.
Angewandte Chemie 2002 Volume 114(Issue 16) pp:
Publication Date(Web):21 AUG 2002
DOI:10.1002/1521-3757(20020816)114:16<3167::AID-ANGE3167>3.0.CO;2-K

Mimetika im Hinblick auf die Geometrie oder Ladung der Fucose-Einheit der GDP-Fucose im Übergangszustand von Fucosyltransferase-katalysierten Reaktionen konnten mit den Verbindungen 13 erhalten werden, welche gute kompetitive Inhibitoren der α-1,3-Fucosyltransferasen V und VI mit Ki-Werten von 6 bis 13 μM sind. GDP=Guanosindiphosphat

Co-reporter:Thomas J. Tolbert Dr.
Angewandte Chemie 2002 Volume 114(Issue 12) pp:
Publication Date(Web):13 JUN 2002
DOI:10.1002/1521-3757(20020617)114:12<2275::AID-ANGE2275>3.0.CO;2-X

Die hoch selektive Tabakätz-Virus-Nla-Protease (TEV-Protease) kann zum Entfernen von Affinitätsmarkern mit mutierten Spaltstellen eingesetzt werden. Hierbei werden Proteine freigesetzt, die an der Spaltstelle spezifisch markiert und durch chemoselektive Ligationen umgesetzt werden können (siehe Schema). Auf diese Weise lassen sich Proteine mit N-terminalen Cysteinen für proteomische Anwendungen einfach und effizient herstellen.

Co-reporter:Xin-Shan Ye, Xuefei Huang and Chi-Huey Wong  
Chemical Communications 2001 (Issue 11) pp:974-975
Publication Date(Web):10 May 2001
DOI:10.1039/B102166B
New sialyl donors with a protected hydroxymethyl group at the anomeric center are over 1000 times more reactive than the normal ester containing sialylation reagent and give excellent yield (>90%) with unusually high β-stereoselectivity in sialylation.
Co-reporter:Michael Mitchell;Lei Qaio
Advanced Synthesis & Catalysis 2001 Volume 343(Issue 6-7) pp:
Publication Date(Web):28 AUG 2001
DOI:10.1002/1615-4169(200108)343:6/7<596::AID-ADSC596>3.0.CO;2-V

Fuculose 1-phosphate and fructose-diphosphate aldolases were employed in the chemoenzymatic synthesis of the iminocyclitols 1 and 2 possessing a phosphonic acid moiety. These compounds are useful as core synthons for the development of specific glycosyltransferase inhibitors.

Co-reporter:Xuefei Huang;Krista L. Witte;David E. Bergbreiter
Advanced Synthesis & Catalysis 2001 Volume 343(Issue 6-7) pp:
Publication Date(Web):28 AUG 2001
DOI:10.1002/1615-4169(200108)343:6/7<675::AID-ADSC675>3.0.CO;2-2

Several enzymes immobilized on thermo-responsive polyacrylamide polymers are nearly as active as their soluble forms, and can be recovered for reuse after gentle heating and precipitation. Carbohydrates attached to these polymers have been used for enzymatic glycosylation, and the products have been isolated by thermal precipitation followed by release from the polymer, thus greatly simplifying product purification in water.

Co-reporter:Chi-Huey Wong
Advanced Synthesis & Catalysis 2001 Volume 343(Issue 6-7) pp:
Publication Date(Web):28 AUG 2001
DOI:10.1002/1615-4169(200108)343:6/7<495::AID-ADSC495>3.0.CO;2-2
Co-reporter:Van-Duc Le, Chi Ching Mak, Ying-Chuan Lin, John H. Elder, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2001 Volume 9(Issue 5) pp:1185-1195
Publication Date(Web):May 2001
DOI:10.1016/S0968-0896(00)00346-1
The interaction of P1 and P3 side chains with the combining S1 and S3 hydrophobic subsites of HIV and FIV proteases has been explored using asymmetric competitive inhibitors. The inhibitors evaluated contained (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid (allophenylnorstatine) as the hydroxymethylcarbonyl isostere, (R)-5,5-dimethyl-1, 3-thiazolidine-4-carbonyl as P1′, Val as P2 and P2′ residues, and a variety of amino acids at the P3 and P3′ positions. All inhibitors showed competitive inhibition of both enzymes with higher potency against the HIV protease in vitro. Within this series, 31 (VLE776) is the most effective inhibitor against FIV protease, and it contains Phe at P3, but no P3′ residue. VLE776 also exhibited potent antiviral activities against the drug-resistant HIV mutants (G48V and V82F) and the TL3-resistant HIV mutants. Explanation of the inhibition activities was described. In addition, a new strategy was described for development of bifunctional inhibitors, which combine the protease inhibitor and another enzyme inhibitor in one molecule.Graphic
Co-reporter:Chi Ching Mak, Van-Duc Le, Ying-Chuan Lin, John H Elder, Chi-Huey Wong
Bioorganic & Medicinal Chemistry Letters 2001 Volume 11(Issue 2) pp:219-222
Publication Date(Web):January 2001
DOI:10.1016/S0960-894X(00)00641-7
A series of norstatine-based HIV/FIV protease inhibitors incorporating a 15-membered macrocycle as a mimic of the tri-peptide (Ala-Val-Phe), a motif with a small P3′ residue effective against the FIV protease and the drug-resistant HIV proteases, has been synthesized. It was found that the macrocycle is important to the overall activity of the inhibitors. Certain inhibitors were developed expressing low nanomolar inhibitory activity against the HIV/FIV proteases and they are also effective against some drug-resistant as well as TL3-resistant HIV proteases.Macrocyclic HIV/FIV protease inhibitors with low nanomolar inhibitory activity were synthesized.
Co-reporter:Thomas K. Ritter Dr.
Angewandte Chemie 2001 Volume 113(Issue 19) pp:
Publication Date(Web):2 OCT 2001
DOI:10.1002/1521-3757(20011001)113:19<3616::AID-ANGE3616>3.0.CO;2-B

Das große Interesse am Problem der Antibiotikaresistenz führte in letzter Zeit zur Entdeckung neuer Targets und Strategien in der Antibiotikaforschung. Eine neue Richtung der Strategien ist die Entwicklung kleiner Moleküle, die Kohlenhydratrezeptoren und Kohlenhydrat-modifizierende Enzyme angreifen. Dieser Aufsatz stellt neuere Arbeiten auf diesem Gebiet vor und diskutiert den Einfluss der jeweiligen Vorgehensweisen auf das Auftreten von Resistenz. Von besonderem Interesse sind die einzigartigen Kohlenhydrate der Zelloberfläche, die an der Peptidoglycan-Biosynthese beteiligte Transglycosylase sowie die RNA der Bakterien. Mit zunehmendem Verständnis des Genoms verschiedener Bakterienarten und Fortschritten in der funktionalen Genomforschung und Proteomforschung, ist die Entdeckung einer Vielzahl von Targets für die Entwicklung neuer Antibiotika zu erwarten.

Co-reporter:Thomas K. Ritter Dr.
Angewandte Chemie International Edition 2001 Volume 40(Issue 19) pp:
Publication Date(Web):2 OCT 2001
DOI:10.1002/1521-3773(20011001)40:19<3508::AID-ANIE3508>3.0.CO;2-I

Recent interest in the problem of antibiotic resistance has led to the identification of new targets and strategies for antibiotic discovery. Among these efforts, the development of small molecules as antibiotics to target carbohydrate receptors or carbohydrate-modifying enzymes represents a new direction. This review covers recent work in this regard and discusses the impact of each strategy on the development of drug resistance. Particularly interesting targets include unique cell-surface carbohydrates, the transglycosylase involved in peptidoglycan biosynthesis, and bacterial RNA. With a greater understanding of the genome of different bacteria as well as advances in functional genomics and proteomics, we can expect the discovery of a variety of targets for the development of novel antibiotics.

Co-reporter:Chung-Shan Yu Dr.;Kenichi Niikura Dr.;Chun-Cheng Lin Dr. Dr.
Angewandte Chemie 2001 Volume 113(Issue 15) pp:
Publication Date(Web):3 AUG 2001
DOI:10.1002/1521-3757(20010803)113:15<2984::AID-ANGE2984>3.0.CO;2-5

5-Azidosialyl-Donoren mit O-Acetyl-Schutzgruppen sind besonders gute Reagentien für die α-selektive Glycosylierung primärer Hydroxygruppen als Acceptoren. Dies belegt eine Vielzahl von Reaktionen mit 1 als Sialyldonor. Es gelang auch, NeuAcα(29)NeuAc als Thioglycosid-Donor für den Einsatz in weiteren Glycosylierungen zu synthetisieren.

Co-reporter:Chung-Shan Yu Dr.;Kenichi Niikura Dr.;Chun-Cheng Lin Dr. Dr.
Angewandte Chemie International Edition 2001 Volume 40(Issue 15) pp:
Publication Date(Web):2 AUG 2001
DOI:10.1002/1521-3773(20010803)40:15<2900::AID-ANIE2900>3.0.CO;2-4

5-Azido sialyl donors with O-acetyl protecting groups are useful α-selective glycosylation reagents, especially for primary hydroxyl groups as acceptors. This is shown with a variety of reactions using 1 as a sialyl donor. It was also possible to synthesize NeuAcα(29)NeuAc as a thioglycoside donor for use in subsequent glycosylations.

Co-reporter:Steven J Sucheck, Chi-Huey Wong
Current Opinion in Chemical Biology 2000 Volume 4(Issue 6) pp:678-686
Publication Date(Web):1 December 2000
DOI:10.1016/S1367-5931(00)00142-3
Proteins are folded to form a small binding site for catalysis or ligand recognition and this small binding site is traditionally the target for drug discovery. An alternative target for potential drug candidates is the translational process, which requires a precise reading of the entire mRNA sequence and, therefore, can be interrupted with small molecules that bind to mRNA sequence-specifically. RNA thus presents itself as a new upstream target for drug discovery because of the critical role it plays in the life of pathogens and in the progression of diseases. In this post-genomic era, RNA is becoming increasingly amenable to small-molecule therapy as greater structural and functional information accumulates with regard to important RNA functional domains. The study of aminoglycoside antibiotics and their binding to 16S ribosomal RNA has been a paradigm for our understanding of the ways in which small molecules can be developed to affect the function of RNA.
Co-reporter:Arno Düffels, Luke G. Green, Roman Lenz, Steven V. Ley, Stephane P. Vincent, Chi-Huey Wong
Bioorganic & Medicinal Chemistry 2000 Volume 8(Issue 10) pp:2519-2525
Publication Date(Web):October 2000
DOI:10.1016/S0968-0896(00)00187-5
l-Galactosylated dimeric sialyl Lewis X (SLex) has been prepared employing a combination of chemical and enzymatic synthetic methods. GDP-l-galactose has been chemically synthesised. Enzymatic transfer of l-galactose onto the acceptor (Sia-α2,3-Gal-β1,4-GlcNAc-β1,3/6)2-Man-α1-OMe was achieved using the human α-1,3-fucosyltransferase V.
Co-reporter:Kathryn M. Koeller Dr.
Chemistry - A European Journal 2000 Volume 6(Issue 7) pp:
Publication Date(Web):3 APR 2000
DOI:10.1002/(SICI)1521-3765(20000403)6:7<1243::AID-CHEM1243>3.0.CO;2-J

The decasaccharide sialyl-trimeric-Lewis x is a component of glycoproteins and glycolipids that serve as E- and P-selectin ligands. The synthesis of this target structure was accomplished by utilizing a combination of chemical and enzymatic methods. Highlights of the chemical synthesis include minimal use of protecting groups and regioselective glycosylations to arrive at a linear tri-lactosamine structure. Glycosyltransferase-catalyzed reactions were then employed for the addition of the terminal sialic acid and branch-point fucose residues. Notably, fucosyltransferases V and VI showed different specificities for the sialyl-tri-lactosamine core structure.

Co-reporter:Valentin Wittmann Dr.;Arun K. Datta Dr.;Kathryn M. Koeller Dr.
Chemistry - A European Journal 2000 Volume 6(Issue 1) pp:
Publication Date(Web):29 DEC 1999
DOI:10.1002/(SICI)1521-3765(20000103)6:1<162::AID-CHEM162>3.0.CO;2-9

Sialyl Lewis × (sLex) derivatives conjugated to readily visualized molecular labels are useful chemical probes to study selectin-carbohydrate interactions. Localization of the selectins on the surface of leukocytes and activated endothelial cells can be detected through fluorescence of bound selectin ligands. Herein we present a short chemoenzymatic synthesis of a fluorescently labeled bivalent sLex conjugate. The use of an amino-substituted monovalent sLex to obtain fluorescent- and biotin-labeled sLex derivatives is also described. The cell-staining utility of the fluorescent sLex conjugates is demonstrated for a HUVEC cell line expressing E-selectin and for CHO-K1 cells expressing either L- or E-selectin.

Co-reporter:Osamu Kanie Dr.;Gijsbert Grotenbreg
Angewandte Chemie 2000 Volume 112(Issue 24) pp:
Publication Date(Web):15 DEC 2000
DOI:10.1002/1521-3757(20001215)112:24<4719::AID-ANGE4719>3.0.CO;2-B

So mild und effektiv wie die konventionelle Hydrogenolyse in Lösung ist die Abspaltung von Benzylgruppen an Kohlenhydraten, die an ein festes Trägermaterial gebunden sind, mit Palladium-Nanoteilchen als Katalysatoren. Der Einsatz eines UV-aktiven Linkers, der die benzylgeschützten Glycoside von Glucose, Fucose und Lactose an den Träger bindet (siehe Bild), ermöglicht es, den Verlauf der Hydrogenolyse nach der Abspaltung vom Träger zu verfolgen.

Co-reporter:Timothy D. Machajewski Dr. Dr.
Angewandte Chemie 2000 Volume 112(Issue 8) pp:
Publication Date(Web):13 APR 2000
DOI:10.1002/(SICI)1521-3757(20000417)112:8<1406::AID-ANGE1406>3.0.CO;2-R

Die Knüpfung von C-C-Bindungen unter vollständiger Kontrolle des stereochemischen Verlaufs einer Reaktion ist in der organischen Synthesechemie von großer Bedeutung. Die Aldolreaktion, d. h. die einfache Addition eines Enolatdonors an einen Carbonylacceptor, ist eine der bedeutendsten Reaktionen, die dem Synthesechemiker zur Verfügung stehen. Im Allgemeinen wird die Kontrolle der relativen und absoluten Konfiguration des neugebildeten Stereozentrums durch die Verwendung von chiralen Ausgangsverbindungen oder chiralen Hilfsreagentien erzielt. In den letzten Jahren wurden in der organischen Synthesechemie große Anstrengungen bei der Suche nach katalytischen Methoden unternommen, die die chirale Information auf effiziente Weise übertragen. Zwei verschiedene Zugänge zur katalysierten asymmetrischen Aldolreaktion wurden dabei in Erwägung gezogen: Biokatalyse und die Katalyse durch kleine Moleküle. Beide Methoden haben sowohl spezifische Vorteile als auch Grenzen und sind daher in vielen Bereichen komplementär zueinander. In diesem Artikel werden die wichtigsten neuen Entwicklungen bei beiden Methoden zusammengefasst.

Co-reporter:Steven J. Sucheck Dr.;William A. Greenberg Dr.;Thomas J. Tolbert Dr. Dr.
Angewandte Chemie 2000 Volume 112(Issue 6) pp:
Publication Date(Web):21 MAR 2000
DOI:10.1002/(SICI)1521-3757(20000317)112:6<1122::AID-ANGE1122>3.0.CO;2-V
Co-reporter:Michael D. Burkart;Masayuki Izumi
Angewandte Chemie International Edition 1999 Volume 38(Issue 18) pp:
Publication Date(Web):15 SEP 1999
DOI:10.1002/(SICI)1521-3773(19990917)38:18<2747::AID-ANIE2747>3.0.CO;2-2

A cost-efficient preparative enzymatic sulfation of oligosaccharides has been developed. Starting from adenosine 3′5′-diphosphate (PAP), the sulfate donating and highly expensive cofactor 3′-phosphoadenosine-5′-phosphosulfate (PAPS, 1) can be regenerated by using a recombinant aryl sulfotransferase and p-nitrophenyl sulfate. This system averts product inhibition by PAP and can serve as a continuous spectrophotometric assay for the activity of any sulfotransferase enzyme.

Co-reporter:Michael D. Burkart;Masayuki Izumi
Angewandte Chemie 1999 Volume 111(Issue 18) pp:
Publication Date(Web):15 SEP 1999
DOI:10.1002/(SICI)1521-3757(19990917)111:18<2912::AID-ANGE2912>3.0.CO;2-X

Preiswerter als zuvor können Oligosaccharide jetzt präparativ enzymatisch sulfatiert werden. Ausgehend von Adenosin-3′,5′-diphosphat (PAP) kann jetzt der als Sulfatgruppen-Donor dienende, teure Cofaktor 3′-Phosphoadenosin-5′-phosphosulfat (PAPS) 1 mit einer neuen Methode unter Verwendung einer rekombinanten Aryl-Sulfotransferase und p-Nitrophenylsulfat regeneriert werden. Dieses System unterliegt nicht der Produkthemmung durch PAP und kann als kontinuierlicher spektrophotometrischer Assay für die kinetische Analyse von Sulfotransferasen eingesetzt werden.

Co-reporter:Pamela Sears
Angewandte Chemie International Edition 1999 Volume 38(Issue 16) pp:
Publication Date(Web):6 AUG 1999
DOI:10.1002/(SICI)1521-3773(19990816)38:16<2300::AID-ANIE2300>3.0.CO;2-6

Useful strategies for the design of molecules to mimic carbohydrates have been developed over the past few years. Mimics of the target may contain new functional groups, a new scaffold, or both (in the schematic representation the natural ligand is shown on the left and the modified version on the right). Many examples of successful carbohydrate mimetics that interfere with sugar–protein and sugar–nucleic acid interactions are known.

Co-reporter:Dominique Depré;Arno Düffels;Luke G. Green;Roman Lenz;Steven V. Ley
Chemistry - A European Journal 1999 Volume 5(Issue 11) pp:
Publication Date(Web):29 OCT 1999
DOI:10.1002/(SICI)1521-3765(19991105)5:11<3326::AID-CHEM3326>3.0.CO;2-Q

The concise synthesis of nine diantennary oligosaccharides, such as 1, by chemical and chemoenzymatic protocols is presented. The compounds display Lewis X, Lewis Y, sialyl Lewis X and T-antigen epitopes supported on a 3,6-branched trimannose core. They derive from the glycans of the human glycoproteins Glycodelin-A and Glycodelin-S believed to be involved in regiospecific suppression of the female immune system.

Co-reporter:Pamela Sears
Angewandte Chemie 1999 Volume 111(Issue 16) pp:
Publication Date(Web):6 AUG 1999
DOI:10.1002/(SICI)1521-3757(19990816)111:16<2446::AID-ANGE2446>3.0.CO;2-4

Zahlreiche nützliche Strategien für das Design von Molekülen, die Kohlenhydrate nachahmen, wurden in den letzten Jahren entwickelt. Mimetika der Targets können neue funktionelle Gruppen und/oder neue Gerüste enthalten (in der schematischen Darstellung ist der natürliche Ligand links und der modifizierte rechts gezeigt). Es liegen bislang viele Beispiele für Kohlenhydratmimetika vor, die Zucker-Protein- und Zucker-Nucleinsäure-Wechselwirkungen effizient stören.

Co-reporter:Hiroshi Kamitakahara;Takashi Suzuki;Noriko Nishigori;Yasuo Suzuki;Osamu Kanie
Angewandte Chemie 1998 Volume 110(Issue 11) pp:
Publication Date(Web):12 MAR 1999
DOI:10.1002/(SICI)1521-3757(19980605)110:11<1607::AID-ANGE1607>3.0.CO;2-H

Nach dem Prinzip mehrfacher Wechselwirkungen könnte das amphiphile Polymer 1, das in wäßriger Lösung als Aggregat vorliegt (siehe unten rechts), eine Infektion mit dem Influenzavirus verhindern. Nach der Erkennung des spezifischen Sialyllactose-Epitops durch Hämagglutinin (HA) auf der Virusoberfläche bilden der Sphingosinrest und der Fluoreszenzmarker durch hydrophobe Wechselwirkungen einen stabilen Komplex mit HA. 1 weist eine 106fach höhere In-vitro-Inhibierungsaktivität auf als Sialyllactose. PGA = Polyglutaminsäure.

Co-reporter:J. Heather Hogg;Ian R. Ollmann;Anders Wetterholm;Martina Blomster Andberg;Jesper Haeggström;Bengt Samuelsson
Chemistry - A European Journal 1998 Volume 4(Issue 9) pp:
Publication Date(Web):14 DEC 1998
DOI:10.1002/(SICI)1521-3765(19980904)4:9<1698::AID-CHEM1698>3.0.CO;2-J

The synthesis of a potent competitive LTA4hydrolase inhibitor (A, Ki=1.6 nM) prompted an investigation into the biological activity of A against LTB4 biosynthesis, as well as the design, synthesis, and evaluation of a new series of inhibitors B to further probe the active site of LTA4 hydrolase. On the basis of these results, and previously reported site-directed mutagenesis and inhibition studies, the mechanisms of peptide and epoxide hydrolysis catalyzed by LTA4 hydrolase are discussed.

Co-reporter:Hiroshi Kamitakahara;Takashi Suzuki;Noriko Nishigori;Yasuo Suzuki;Osamu Kanie
Angewandte Chemie International Edition 1998 Volume 37(Issue 11) pp:
Publication Date(Web):17 DEC 1998
DOI:10.1002/(SICI)1521-3773(19980619)37:11<1524::AID-ANIE1524>3.0.CO;2-D

Based on the principle of a multivalent interaction, the amphiphilic polymer 1, present in solution as an aggregate (see below right), is able to inhibit infection with the influenza virus. After recognition of a specific sialyllactose epitope through hemaglutinin (HA) on the virus surface, the sphingosine residues and the fluorescent tag form a stable complex with HA through hydrophobic interactions. Polymer 1 shows in vitro inhibitory activity 106-fold greater than that of sialyllactose. PGA=polyglutamic acid.

Co-reporter:Takuya Kanemitsu;Osamu Kanie
Angewandte Chemie International Edition 1998 Volume 37(Issue 24) pp:
Publication Date(Web):18 JAN 1999
DOI:10.1002/(SICI)1521-3773(19981231)37:24<3415::AID-ANIE3415>3.0.CO;2-8

Just tagging along. For the nondestructive quantitative monitoring of solid-phase oligosaccharide synthesis a 13C-enriched tag (*) was incorporated in the linker and a 13C-enriched protecting group (⧫) was included in the growing molecule. By integration of the signals in a gated decoupling 13C NMR experiment the reaction progress can be monitored. This method was demonstrated with the synthesis of sialyl Lewisx tetrasaccharide on a Tentagel support ((P)). Bn=benzyl, PEG=poly(ethylene glycol).

Co-reporter:Glenn J. McGarvey
European Journal of Organic Chemistry 1997 Volume 1997(Issue 6) pp:
Publication Date(Web):25 JAN 2006
DOI:10.1002/jlac.199719970604

Carbohydrates are increasingly appreciated for their critical roles in biological functions. Driving these studies addressing the molecular basis of carbohydrate-mediated events is the availability of natural and unnatural carbohydrates. Recently, new methods of enzymatic synthesis have been developed that now afford rapid access to complex, structurally diverse oligosaccharides on large scales. This methodology has been essential to gaining insight into the molecular details of important carbohydrate recognition phenomena that are associated with many signaling processes. This review summarizes recent chemical studies examining selectin/sialyl Lewisx binding, a key event in inflammation and metastasis, and describes the development of carbohydrate mimetics that may offer leads to new therapeutic agents. In addition, combinatorial synthesis has been used to prepare carbohydrate mimetics to neomycin B, an aminoglycoside that binds RNA involved in HIV infection, and chemoenzymatic methodology has been applied to the design and synthesis of mechanism-based inhibitors of glycoprocessing enzymes.

Co-reporter:Charng-Sheng Tsai, Po-Yu Liu, Hsin-Yung Yen, Tsui-Ling Hsu and Chi-Huey Wong
Chemical Communications 2010 - vol. 46(Issue 30) pp:NaN5577-5577
Publication Date(Web):2010/05/13
DOI:10.1039/C0CC00345J
A new trifunctional probe, assembled using a cleavable linker, is useful for efficient enrichment and detection of alkynyl sugar-tagged biomolecules.
Co-reporter:Clay S. Bennett and Chi-Huey Wong
Chemical Society Reviews 2007 - vol. 36(Issue 8) pp:NaN1238-1238
Publication Date(Web):2007/05/14
DOI:10.1039/B617709C
The construction of homogeneous glycoproteins presents a formidable challenge to the synthetic chemist. Over the past few years there has been an explosion in the number of methods developed to address this problem. These methods include the development of novel ligation technologies for the synthesis of the protein backbone, as well chemical and enzymatic approaches for introducing complex glycans into the peptide backbone. This tutorial review discusses the application of these techniques to the synthesis of peptides and proteins possessing well defined glycans.
2H-PYRAN-2-ONE, 6-(2-AZIDOETHYL)TETRAHYDRO-4-HYDROXY-, (4R,6R)-
2-BUTANONE, 3-(ACETYLOXY)-4-(1,3-DITHIAN-2-YL)-, (3S)-
L-manno-2-Octulosonic acid, 3-deoxy-
6-Octadecen-1-ol, 2-azido-3,4-bis(phenylmethoxy)-, (2S,3S,4R,6E)-
b-D-Glucopyranoside,4-methoxyphenyl 4-O-[2,6-bis-O-(phenylmethyl)-b-D-galactopyranosyl]-2,3,6-tris-O-(phenylmethyl)-
[1,2,3]Triazolo[1,5-a]pyridine-3-carboxylic acid,4,5,6,7-tetrahydro-4,5,6-trihydroxy-7-methyl-, methyl ester,(4R,5R,6R,7R)-
[1,2,3]Triazolo[1,5-a]pyridine-3-carboxylic acid,4,5,6,7-tetrahydro-7-methyl-4,5,6-tris(phenylmethoxy)-, methyl ester,(4R,5R,6R,7R)-
D-erythro-Pentose, 2,5-dideoxy-, 3-acetate